The use of triclosan eluting stents effectively reduces ureteral stent symptoms: A prospective randomized trial

BJU International

Volumn 110, Issue 5, 2012, Pages 749-754

  Mendez Probst, Carlos E ^a   Goneau, Lee W ^a,b   MacDonald, Kyle W ^a,b   Nott, Linda ^a   Seney, Shannon ^b   Elwood, Chelsea N ^b,c   Lange, Dirk ^c   Chew, Ben H ^a,c   Denstedt, John D ^a,b   Cadieux, Peter A ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

anti inflammatory agent; drug eluting stent; stent symptoms; triclosan; ureteral stent

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; GENTAMICIN; LEVOFLOXACIN; TRICLOSAN;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ADHERENCE; BIOFILM; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE INFECTION; DEVICE REMOVAL; DRUG ELUTING STENT; DRUG USE; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FLANK PAIN; HUMAN; INFECTION PREVENTION; INFECTION RATE; MALE; MICTURITION; PAIN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; URETER STENT; URETERAL STENT RELATED SYMPTOM; URETEROSCOPY; URETHRAL PAIN; URINARY TRACT DISEASE; URINE CULTURE;

ABDOMINAL PAIN; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; DEVICE REMOVAL; DRUG-ELUTING STENTS; EQUIPMENT CONTAMINATION; FEMALE; FLANK PAIN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; PROSTHESIS-RELATED INFECTIONS; TRICLOSAN;

EID: 84865320214     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10903.x     Document Type: Article

References (21)

1. Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ,. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 2003; 169: 1065-9 (Pubitemid 36188160)
2. Venkatesan N, Shroff S, Jayachandran K, Doble M,. Polymers as ureteral stents. J Endourol 2010; 24: 191-8
3. Shaw GL, Choong SK, Fry C,. Encrustation of biomaterials in the urinary tract. Urol Res 2005; 33: 17-22 (Pubitemid 40487188)
4. Mosli HA, Farsi HM, al-Zimaity MF, Saleh TR, al-Zamzami MM,. Vesicoureteral reflux in patients with double pigtail stents. J Urol 1991; 146: 966-9
5. Payne SR, Ramsay JW,. The effects of double J stents on renal pelvic dynamics in the pig. J Urol 1988; 140: 637-41
6. Smedley FH, Rimmer J, Taube M, Edwards L,. 168 double J (pigtail) ureteric catheter insertions: a retrospective review. Ann R Coll Surg Engl 1988; 70: 377-9 (Pubitemid 18267751)
7. Joshi HB, Okeke A, Newns N, Keeley FX Jr, Timoney AG,. Characterization of urinary symptoms in patients with ureteral stents. Urology 2002; 59: 511-6 (Pubitemid 34249872)
8. Ramsay JW, Crocker RP, Ball AJ, et al. Urothelial reaction to ureteric intubation. A clinical study. Br J Urol 1987; 60: 504-5 (Pubitemid 18002590)
9. Elwood CN, Lange D, Nadeau R, et al. Novel in vitro model for studying ureteric stent-induced cell injury. BJU Int 2010; 105: 1318-23
10. Chew BH, Cadieux PA, Reid G, Denstedt JD,. In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens. J Endourol 2006; 20: 949-58 (Pubitemid 44907031)
11. Cadieux PA, Chew BH, Knudsen BE, et al. Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model. J Urol 2006; 175: 2331-5 (Pubitemid 43668543)
12. Cadieux PA, Chew BH, Nott L, et al. Use of triclosan-eluting ureteral stents in patients with long-term stents. J Endourol 2009; 23: 1187-94
13. Elwood CN, Chew BH, Seney S, Jass J, Denstedt JD, Cadieux PA,. Triclosan inhibits uropathogenic Escherichia coli-stimulated tumor necrosis factor-alpha secretion in T24 bladder cells in vitro. J Endourol 2007; 21: 1217-22 (Pubitemid 47614367)
14. Mustafa M, Wondimu B, Yucel-Lindberg T, Kats-Hallstrom AT, Jonsson AS, Modeer T,. Triclosan reduces microsomal prostaglandin E synthase-1 expression in human gingival fibroblasts. J Clin Periodontol 2005; 32: 6-11 (Pubitemid 40187418)
15. Xu T, Deshmukh M, Barnes VM, Trivedi HM, Cummins D,. Effectiveness of a triclosan/copolymer dentifrice on microbiological and inflammatory parameters. Compend Contin Educ Dent 2004; 25 (Suppl. 1): 46-53
16. Beiko DT, Watterson JD, Knudsen BE, et al. Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy. J Endourol 2004; 18: 723-30 (Pubitemid 39441760)
17. Kjaerheim V, Barkvoll P, Waaler SM, Rolla G,. Triclosan inhibits histamine-induced inflammation in human skin. J Clin Periodontol 1995; 22: 423-6
18. Barkvoll P, Rolla G,. Triclosan protects the skin against dermatitis caused by sodium lauryl sulphate exposure. J Clin Periodontol 1994; 21: 717-9
19. Krambeck AE, Walsh RS, Denstedt JD, et al. A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J Urol 2010; 183: 1037-42
20. Norris RD, Sur RL, Springhart WP, et al. A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort. Urology 2008; 71: 792-5
21. Sur RL, Haleblian GE, Cantor DA, Springhart WP, Albala DM, Preminger GM,. Efficacy of intravesical ropivacaine injection on urinary symptoms following ureteral stenting: a randomized, controlled study. J Endourol 2008; 22: 473-8 (Pubitemid 351430738)